Todavía no hay suficientes señales de compra con un horizonte T+90 consolidado para medir un historial.
Historial de señales
Browse the full record of transactions filed by Deschatelets Pascal, Chief Scientific Officer. Insider active across 2 companies, notably Apellis Pharmaceuticals, Inc.. Aggregated, 62 filings have been recorded. Split: 0 buy · 20 sells. Total volume traded: €10m. History available since 24 May 2021. The latest transaction was disclosed on 28 January 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Deschatelets Pascal
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12.000 títulos@ 40,38 US$3.8% de su flujoCommon StockSEC:0001127602-23-025708:1
25 de 62 declaraciones
About Deschatelets Pascal
Deschatelets Pascal is Chief Scientific Officer at Apellis Pharmaceuticals, Inc. He has 62 filings in total, and across the sampled recent filings the transactions are sales for EUR 9,979,624 between 2021-05-25 and 2026-05-14, with the transaction nature shown as option exercise.